Table 1.

Treatment information on study animals in the 10% imidacloprid + 2.5% moxidectin (Advantage Multi®) and nontreated groups

Treatment group	Gender	Dog ID#	Study day	Body weight (pounds)	Dose (mL)
Group 1: 10% imidacloprid + 2.5% moxidectin	Female	1531603	−30	29.0	2.5
	Female	1531805	−30	16.6	1.0
	Female	1531806	−30	18.6	1.0
	Female	1531903	−30	19.0	1.0
	Male	1531502	−30	21.0	2.5
	Male	1531801	−30	25.4	2.5
	Male	1531802	−30	24.2	2.5
	Male	1531901	−30	30.6	2.5
Group 2: no treatment	Female	1531503	−30	17.6	0
	Female	1531702	−30	25.2	0
	Female	1531706	−30	25.0	0
	Female	1531803	−30	19.6	0
	Female	1531804	−30	17.8	0
	Female	1532203	−30	19.0	0
	Male	1531501	−30	32.4	0
	Male	1532101	−30	30.4	0